Sun Pharma introduces anti-cancer product in Europe


Posted on:12 Jul 2016 11:53:48

Sun Pharma introduces anti-cancer product in Europe
12 July 2016 Current Affairs: Sun Pharmaceutical Industries announced rollout of Gemcitabine InfuSMART, on Monday, used in treatment of cancer, in Europe.

Sun Pharma has announced rollout of Gemcitabine InfuSMART in Europe. InfuSMART is a technology in which oncology products are developed in a ready-to-administer (RTA) bag.

Sun Pharma's Gemcitabine InfuSMART ready-to-administer infusion products provide the combined advantage of long stable compounded medicine along with safety... Traditionally, such medicines are compounded at hospitals (in-house) or outsourced to compounding pharmacies, making it a time-consuming and potentially hazardous process.

Launch of InfuSMART will help us remain a meaningful player in the global oncology therapy market by offering differentiating cancer treatment solutions. We believe there are opportunities for us to expand our portfolio of ready-to-administer products across multiple therapies where time and safety are an important element of treatment.

Sun Pharma has received regulatory approval to produce Gemcitabine InfuSMART in eight key SKUs (stock keeping units).

More InfuSMART oncology products are currently in Sun Pharma's pipeline to be rolled out in future.


Subscribe to Current Affairs

Enter your email to get daily current affairs

Current Affairs June 2017

23 JUNE
NEWS
22 JUNE
NEWS
21 JUNE
NEWS
20 JUNE
NEWS

Current Affairs May 2017

31 MAY
NEWS
30 MAY
NEWS
29 MAY
NEWS
27 MAY
NEWS

Current Affairs April 2017

29 APRIL
NEWS
28 APRIL
NEWS
27 APRIL
NEWS
26 APRIL
NEWS